Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 7/20 | 0.55 |
| ▸ | AKR1C3 | P42330 | 6/20 | 0.53 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8208572 | 1.00 | HTR6 (0.55) | HTR6AKR1C3AKR1C2CHRM3CHRNB2 | |
| SCHEMBL8209785 | 0.90 | HTR6 (0.64) | HTR6AKR1C3AKR1C2CHRM3CHRNB2 | |
| SCHEMBL8209782 | 0.90 | HTR6 (0.64) | HTR6AKR1C3AKR1C2CHRM3CHRNB2 | |
| SCHEMBL8201597 | 0.89 | AKR1C3 (0.56) | HTR6AKR1C3AKR1C2AKR1C4PTGS1 | |
| SCHEMBL8201592 | 0.89 | AKR1C3 (0.56) | HTR6AKR1C3AKR1C2AKR1C4PTGS1 | |
| SCHEMBL8213326 | 0.86 | HTR6 (0.56) | HTR6 | |
| SCHEMBL8200923 | 0.86 | HTR6 (0.56) | HTR6 | |
| SCHEMBL8208595 | 0.79 | HTR6 (0.82) | HTR6 | |
| SCHEMBL8213978 | 0.79 | HTR6 (0.82) | HTR6 | |
| SCHEMBL6965707 | 0.78 | HTR6 (0.49) | HTR6CHRNB2CHRNA5CHRNA7CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6100291-A | FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 2000-08-08 | — | — | US | disclosed |
| WO-1999047516-A1 | 3-(2-PYRROLIDINYLMETHYL)-INDOLE COMPOUNDS HAVING 5-HT6 AFFINITY | SLASSI ABDELMALIK (CA) | 1999-09-23 | — | — | WO | disclosed |